Eastman Chemical Company (EMN) — Fair Value Analysis

Base-case fair value (P50): $85.99 · Current price: $69.95 · Verdict: Undervalued

The Verdict on EMN

Based on our comprehensive Monte Carlo simulations, EASTMAN CHEMICAL (EMN) appears distinctly undervalued at its current market price of $69.95. Our rigorous analysis, which explores thousands of forward scenarios for EMN's future cash flows, consistently indicates a median fair value (P50) of $85.99. This implies a substantial potential +22.9% from the present trading level, making EMN an attractive prospect. The significant divergence between $69.95 and our calculated $85.99 fair value suggests that the market may not yet fully reflect EMN's intrinsic worth across various probabilistic outcomes. This quantitative assessment provides a robust foundation for considering the stock's potential.

How EMN stacks up against peers

EMN's operational and financial health is currently assessed as "average" relative to its sector peers. This quality tier, while not indicating top-tier performance, does not negate the strong undervaluation signal from our models. Despite this average standing, the Monte Carlo analysis identifies a clear opportunity: EMN's $69.95 sits materially below the $85.99 fair value. This implies that even with an average operational footprint, the company's future earnings power, when probabilistically modeled, supports a higher valuation. The +22.9% from $69.95 to $85.99 should be viewed within the context of EMN's stable, albeit average, fundamental profile.

What this means for investors

For investors closely tracking EASTMAN CHEMICAL, the current trading price of $69.95 juxtaposed against a $85.99 fair value presents a compelling +22.9% opportunity. The "average" quality tier suggests a balanced risk profile, yet the robust Monte Carlo results strongly underpin the case for EMN being undervalued. Investors evaluating EMN at its $69.95 should consider the probabilistic fair value derived from these simulations, as even in more conservative scenarios, the gap to $85.99 remains attractive. To gain a deeper understanding of the full bear and bull case distribution, and to track EMN's fair value as new fundamental data is released, sign up for a free FairCurve account.